What remains is the therapeutic benefit: sustained appetite reduction, improved satiety signals, and continued weight loss or weight maintenance
The joint advisory published by the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society identified specific nutrients at risk during GLP-1 therapy: iron, calcium, magnesium, zinc, and vitamins A, D, E, K, B1, B12, and C
Additionally, they used the key search term diabetic retinopathy. The purpose of the study was to assess the link between these agonists and DR, as Concerns have emerged regarding their potential link to diabetic retinopathy, according to the study
Survodutide (Boehringers GLP-1/glucagon dual agonist) hit 18.7% weight loss in phase 2 (Le Roux 2024 Lancet)
Siempre consulte con un profesional de la salud antes de iniciar cualquier rgimen de suplementos, especialmente si tiene condiciones mdicas preexistentes o toma medicamentos
Some peptides, like GLP-1 agonists used for diabetes and obesity, are fda approved for specific indications